Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK 13.50
-0.80 (-5.59%)
Aug 30, 2024, 4:26 PM CET
Arctic Bioscience AS Revenue
In the year 2023, Arctic Bioscience AS had annual revenue of 33.76M NOK, down -2.07%. Arctic Bioscience AS had revenue of 14.68M in the half year ending December 31, 2023, with 53.71% growth.
Revenue
33.76M
Revenue Growth
-2.07%
P/S Ratio
10.17
Revenue / Employee
1.99M
Employees
355
Market Cap
342.49M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 533.17M |
| Nordhealth AS | 471.77M |
| Nykode Therapeutics AS | 69.44M |
| Photocure ASA | 513.58M |
| Carasent ASA | 254.01M |
| ArcticZymes Technologies ASA | 117.80M |
| Hofseth BioCare ASA | 230.08M |
| Gentian Diagnostics ASA | 151.51M |